Hypersensitivity pneumonitis probably caused by cyclosporine. A case report

Respiratory Medicine

Volumn 92, Issue 12, 1998, Pages 1368-1370

  Roelofs, P M ^a,c   Klinkhamer, P J ^b   Gooszen, H C ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b Regional Laboratory of Pathology   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; PREDNISOLONE;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; BLOOD CULTURE; CASE REPORT; CROHN DISEASE; DYSPNEA; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG LAVAGE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0032408249     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90144-5     Document Type: Article

References (15)

1. Fournier E, Tonnel AB, Gosset P, Wallaert B, Ameisen J. Voisin C. Early neutrophil alveolitis after antigen inhalation in hypersensitivity pneumonitis. Chest 1985; 88: 563-566.
2. White DA, Rankin JA, Stover DE, Gellene RA, Gupta S. Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis 1989; 139:18-21.
3. Drent M, Velzen-Blad van H, Diamant M, Hoogsteden HC, Bosch van den JMM. Relationship between presentation of sarcoidosis and T lymphocyte profile: a study in bronchoalveolar lavage fluid. Chest 1993; 104: 795-800.
4. Drent M, Velzen-Blad van H, Diamant M, Wagenaar SjSc, Donckerwolcke-Bogaert M. Bosch van JMM. Differential diagnostic value of plasma cells in bronchoalveolar lavage fluid. Chest 1993; 103: 1720-1724.
5. Shneerson JM. Steroid-responsive alveolitis associated with ulcerative colitis. Chest 1992; 101: 585-586.
6. Reinoso MA, Schroeder KW, Pisani RJ. Lung disease associated with orally administered mesalamine for ulcerative colitis. Chest 1992; 101: 1469-1471.
7. Cooper JAD Jr, White DA, Matthay RA. Drug-induced pulmonary disease part I: cytotoxic drugs. Am Rev Respir Dis 1986; 133: 321-340.
8. Cooper JAD Jr, White DA, Matthay RA. Drug-induced pulmonary disease part II: non-cytotoxic drugs. Am Rev Respir Dis 1986; 133: 488-505.
9. Rosenow EC III, Myers JL, Swensen SJ. Pisani RJ. Drug-induced pulmonary disease. An update. Chest 1992; 102: 239-250.
10. Rosenow EC III, Martin WJ II. Drug-induced interstitial lung disease. In: Schwarz MI, King TE Jr, eds. Interstitial Lung Disease, 2nd edn. St Louis: Mosby Year Book 1993: 255-270.
11. Myers JL. Pathology of drug-induced lung disease. In: Katzenstein A, Askin F, eds. Surgical Pathology of Non-neoplastic Lung Disease, 2nd end. Philadelphia: WB Saunders, 1990: 97-127.
12. Sandborn WJ, Tremaine WJ. Cyclosporine treatment of inflammatory bowel disease. Mayo Clin Proc 1992; 67: 981-990.
13. Sartor RB. Cyclosporine therapy for inflammatory bowel disease. N Engl J Med 1994; 330: 1897-1898.
14. Sandborn WJ. Cyclosporine therapy for inflammatory bowel disease: definitive answers and remaining questions. Gastroenterology 1995; 109: 1001-1003.
15. Feagan BG, McDonald JW. Cyclosporine in Crohn's disease. Lancet 1997; 349: 1328.